Elissa Kozlov1, XinQi Dong1, Amy S Kelley2,3, Claire K Ankuda2. 1. Institute for Health, Health Policy, and Aging Research, Rutgers University, New Brunswick, New Jersey. 2. Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 3. Geriatric Research Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York.
Abstract
BACKGROUND/ OBJECTIVE: Depression impacts quality of life at all life stages, but the epidemiology of depression in the last year of life is unknown. This study's objectives were to document the epidemiology of depressive symptoms in the year prior to death and to assess how the trajectory of depressive symptoms varies by sociodemographic and clinical factors. DESIGN: Observational, cross-sectional, cohort study using the Health and Retirement Study. SETTING: Population-based survey. PARTICIPANTS: A total of 3274 individuals who died within 12 months after assessment. MEASURES: Primary outcome: eight-item Center for Epidemiologic Studies Depression Scale (CESD-8). Covariates included sociodemographics, self-reported illnesses, and activity of daily living (ADL) limitations. RESULTS: Average CESD-8 score increased over the last year of life, with 59.3% screening positive for depression in the last month before death. Depression symptoms increased gradually from 12 to 4 months before death (increase of 0.05 points/month; 95% confidence interval [CI] = 0.01-0.08 points/month) and then escalated from 4 to 1 months before death (increase of 0.29 points/month; 95% CI = 0.16-0.39 points/month). Women, younger adults, and nonwhite adults all demonstrated higher rates of depressive symptoms. Individuals with cancer reported escalating rates of depressive symptoms at the end of life, while individuals with lung disease and ADL impairment demonstrated persistently high rates throughout the year before death. CONCLUSIONS: This study revealed high rates of depressive symptoms in the last year of life as well as differences in the burden of depressive symptoms. A public health approach must be taken to screen for and appropriately treat symptoms of depression across the lifespan. J Am Geriatr Soc 68:321-328, 2020.
BACKGROUND/ OBJECTIVE:Depression impacts quality of life at all life stages, but the epidemiology of depression in the last year of life is unknown. This study's objectives were to document the epidemiology of depressive symptoms in the year prior to death and to assess how the trajectory of depressive symptoms varies by sociodemographic and clinical factors. DESIGN: Observational, cross-sectional, cohort study using the Health and Retirement Study. SETTING: Population-based survey. PARTICIPANTS: A total of 3274 individuals who died within 12 months after assessment. MEASURES: Primary outcome: eight-item Center for Epidemiologic Studies Depression Scale (CESD-8). Covariates included sociodemographics, self-reported illnesses, and activity of daily living (ADL) limitations. RESULTS: Average CESD-8 score increased over the last year of life, with 59.3% screening positive for depression in the last month before death. Depression symptoms increased gradually from 12 to 4 months before death (increase of 0.05 points/month; 95% confidence interval [CI] = 0.01-0.08 points/month) and then escalated from 4 to 1 months before death (increase of 0.29 points/month; 95% CI = 0.16-0.39 points/month). Women, younger adults, and nonwhite adults all demonstrated higher rates of depressive symptoms. Individuals with cancer reported escalating rates of depressive symptoms at the end of life, while individuals with lung disease and ADL impairment demonstrated persistently high rates throughout the year before death. CONCLUSIONS: This study revealed high rates of depressive symptoms in the last year of life as well as differences in the burden of depressive symptoms. A public health approach must be taken to screen for and appropriately treat symptoms of depression across the lifespan. J Am Geriatr Soc 68:321-328, 2020.
Authors: Jason A Nieuwsma; Ranak B Trivedi; Jennifer McDuffie; Ian Kronish; Dinesh Benjamin; John W Williams Journal: Int J Psychiatry Med Date: 2012 Impact factor: 1.210
Authors: William F Pirl; Joseph A Greer; Lara Traeger; Vicki Jackson; Inga T Lennes; Emily R Gallagher; Pedro Perez-Cruz; Rebecca S Heist; Jennifer S Temel Journal: J Clin Oncol Date: 2012-03-19 Impact factor: 44.544
Authors: T J Hartung; E Brähler; H Faller; M Härter; A Hinz; C Johansen; M Keller; U Koch; H Schulz; J Weis; A Mehnert Journal: Eur J Cancer Date: 2016-12-23 Impact factor: 9.162
Authors: Ashwin A Kotwal; Irena S Cenzer; Linda J Waite; Kenneth E Covinsky; Carla M Perissinotto; W John Boscardin; Louise C Hawkley; William Dale; Alexander K Smith Journal: J Am Geriatr Soc Date: 2021-07-11 Impact factor: 5.562
Authors: Stefano Tancredi; Claudine Burton-Jeangros; René Ruegg; Elena Righi; Anna Kagstrom; Amelie Quesnel Vallee; Arnaud Chiolero; Piet Bracke; Veerle Buffel; Sarah Van De Velde; Stéphane Cullati Journal: Int J Public Health Date: 2022-07-13 Impact factor: 5.100